Your browser doesn't support javascript.
loading
Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia.
How, Joan; Leiva, Orly; Bogue, Thomas; Fell, Geoffrey G; Bustoros, Mark W; Connell, Nathan T; Connors, Jean M; Ghobrial, Irene M; Kuter, David J; Mullally, Ann; Neuberg, Donna; Zwicker, Jeffrey I; Fogerty, Annemarie E; Hobbs, Gabriela S.
Afiliação
  • How J; Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School Boston, MA, 02115, USA; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, H
  • Leiva O; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Bogue T; Division of Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA.
  • Fell GG; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.
  • Bustoros MW; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School Boston, MA, 02115, USA.
  • Connell NT; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School Boston, MA, 02115, USA; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Connors JM; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School Boston, MA, 02115, USA; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Ghobrial IM; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School Boston, MA, 02115, USA.
  • Kuter DJ; Hematology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
  • Mullally A; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School Boston, MA, 02115, USA; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Neuberg D; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.
  • Zwicker JI; Division of Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA.
  • Fogerty AE; Hematology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
  • Hobbs GS; Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. Electronic address: ghobbs@partners.org.
Leuk Res ; 98: 106459, 2020 11.
Article em En | MEDLINE | ID: mdl-33022566
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Hematológicas na Gravidez / Aborto Espontâneo / Nascido Vivo / Trombocitemia Essencial / Modelos Biológicos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Hematológicas na Gravidez / Aborto Espontâneo / Nascido Vivo / Trombocitemia Essencial / Modelos Biológicos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2020 Tipo de documento: Article